Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers
Annika Lundström, Louise Ziegler, Sebastian Havervall, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 10, pp. 5908-5916
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
Tue Wenzel Kragstrup, Helene Søgaard Singh, Ida Grundberg, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252799-e0252799
Open Access | Times Cited: 107
Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients
Miklós Fagyas, Zsolt Fejes, Renáta Sütő, et al.
International Journal of Infectious Diseases (2021) Vol. 115, pp. 8-16
Open Access | Times Cited: 87
ACE2 Shedding and the Role in COVID-19
Jieqiong Wang, Huiying Zhao, Youzhong An
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 63
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2
Lianghui Zhang, Krishna K. Narayanan, Laura Cooper, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 11
Open Access | Times Cited: 45
Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization
Luigi di Filippo, Melin Uygur, Massimo Locatelli, et al.
Endocrine (2023) Vol. 80, Iss. 3, pp. 669-683
Open Access | Times Cited: 35
Endotheliopathy in Acute COVID-19 and Long COVID
Alice G. Vassiliou, Charikleia S. Vrettou, Chrysi Keskinidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8237-8237
Open Access | Times Cited: 30
Quantifying Renin-Angiotensin-System Alterations in COVID-19
Fabrizio Pucci, Filippo Annoni, Robson A.S. Santos, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2755-2755
Open Access | Times Cited: 41
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 17
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15
Inflammatory biomarkers to predict the prognosis of acute bacterial and viral infections
Aline H. de Nooijer, Peter Pickkers, Mihai G. Netea, et al.
Journal of Critical Care (2023) Vol. 78, pp. 154360-154360
Open Access | Times Cited: 15
Update on the Measurement of "Soluble Angiotensin Converting Enzyme 2" in Plasma and its Emerging Significance as a Novel Biomarker of Cardiovascular and Kidney Diseases: A Concise Commentary
Jean Amiral, Rémy Ferol
Transfusion and Apheresis Science (2025) Vol. 64, Iss. 2, pp. 104090-104090
Closed Access
Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS‐CoV‐2 infection
Yannick Galipeau, Nicolas Castonguay, Pauline S. McCluskie, et al.
The FASEB Journal (2025) Vol. 39, Iss. 4
Open Access
An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2
Lianghui Zhang, Krishna K. Narayanan, Laura Cooper, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 21
Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives
Mohammad Sadegh Soltani‐Zangbar, Forough Parhizkar, Mojtaba Abdollahi, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 21
The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic
Marco Prato, Natalia Tiberti, Cristina Mazzi, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 583-583
Open Access | Times Cited: 3
An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity
Saioa Gómez‐Zorita, Iñaki Milton‐Laskibar, Laura García-Arellano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7975-7975
Open Access | Times Cited: 22
Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19
Taylor Morganstein, Ziyad S. Haidar, Joshua Trivlidis, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12955-12955
Open Access | Times Cited: 20
Profile of the Nasopharyngeal Microbiota Affecting the Clinical Course in COVID-19 Patients
Ornella La Fortune Tchoupou Saha, G Dubourg, Abdourahamane Yacouba, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 15
Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2
Vignesh Mariappan, Pajanivel Ranganadin, S. Lokesh, et al.
Biochimie (2022) Vol. 201, pp. 139-147
Open Access | Times Cited: 15
In silico Evaluation of NO-Sartans against SARS-CoV-2
Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi, et al.
Current Drug Discovery Technologies (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 2
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Mariele Montanari, Barbara Canonico, Evelyn Nordi, et al.
Advances in Biological Regulation (2021) Vol. 81, pp. 100820-100820
Open Access | Times Cited: 19
Angiotensin-Converting Enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and hypertension
Onur Elbasan, Feyza Bayram, Ceyda Dinçer Yazan, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288338-e0288338
Open Access | Times Cited: 7
Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2
Noelia Díaz-Troyano, Pablo Gabriel-Medina, Stephen G. Weber, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 886-886
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top